• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E47的强制表达对Lmo2诱导的T细胞白血病有不同影响。

Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

作者信息

Goodings Charnise, Tripathi Rati, Cleveland Susan M, Elliott Natalina, Guo Yan, Shyr Yu, Davé Utpal P

机构信息

Departments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Biostatistics and Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Leuk Res. 2015 Jan;39(1):100-9. doi: 10.1016/j.leukres.2014.11.016. Epub 2014 Nov 29.

DOI:10.1016/j.leukres.2014.11.016
PMID:25499232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4277943/
Abstract

LIM domain only-2 (LMO2) overexpression in T cells induces leukemia but the molecular mechanism remains to be elucidated. In hematopoietic stem and progenitor cells, Lmo2 is part of a protein complex comprised of class II basic helix loop helix proteins, Tal1and Lyl1. The latter transcription factors heterodimerize with E2A proteins like E47 and Heb to bind E boxes. LMO2 and TAL1 or LYL1 cooperate to induce T-ALL in mouse models, and are concordantly expressed in human T-ALL. Furthermore, LMO2 cooperates with the loss of E2A suggesting that LMO2 functions by creating a deficiency of E2A. In this study, we tested this hypothesis in Lmo2-induced T-ALL cell lines. We transduced these lines with an E47/estrogen receptor fusion construct that could be forced to homodimerize with 4-hydroxytamoxifen. We discovered that forced homodimerization induced growth arrest in 2 of the 4 lines tested. The lines sensitive to E47 homodimerization accumulated in G1 and had reduced S phase entry. We analyzed the transcriptome of a resistant and a sensitive line to discern the E47 targets responsible for the cellular effects. Our results suggest that E47 has diverse effects in T-ALL but that functional deficiency of E47 is not a universal feature of Lmo2-induced T-ALL.

摘要

仅含LIM结构域蛋白2(LMO2)在T细胞中的过表达会诱发白血病,但其分子机制仍有待阐明。在造血干细胞和祖细胞中,Lmo2是由II类碱性螺旋-环-螺旋蛋白Tal1和Lyl1组成的蛋白复合物的一部分。后两种转录因子与E47和Heb等E2A蛋白形成异二聚体以结合E盒。在小鼠模型中,LMO2与TAL1或LYL1协同诱导T细胞急性淋巴细胞白血病(T-ALL),并且在人类T-ALL中一致表达。此外,LMO2与E2A的缺失协同作用,提示LMO2通过造成E2A缺陷发挥作用。在本研究中,我们在Lmo2诱导的T-ALL细胞系中验证了这一假说。我们用一种E47/雌激素受体融合构建体转导这些细胞系,该构建体可被4-羟基他莫昔芬强制同源二聚化。我们发现,强制同源二聚化在4个受试细胞系中的2个中诱导生长停滞。对E47同源二聚化敏感的细胞系在G1期积累,进入S期的细胞减少。我们分析了一个耐药细胞系和一个敏感细胞系的转录组,以识别导致细胞效应的E47靶点。我们的结果提示,E47在T-ALL中有多种作用,但E47功能缺陷并非Lmo2诱导的T-ALL的普遍特征。

相似文献

1
Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.E47的强制表达对Lmo2诱导的T细胞白血病有不同影响。
Leuk Res. 2015 Jan;39(1):100-9. doi: 10.1016/j.leukres.2014.11.016. Epub 2014 Nov 29.
2
A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.TAL1 的一个 DNA 结合突变体与 LMO2 协同作用导致小鼠 T 细胞白血病。
Oncogene. 2011 Mar 10;30(10):1252-60. doi: 10.1038/onc.2010.495. Epub 2010 Nov 8.
3
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.Lyl1 在 Lmo2 驱动的早期 T 细胞前体 ALL 模型中的需求。
Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.
4
Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.血管生成素-2 是内皮细胞中 TAL1、LYL1 和 LMO2 的直接转录靶标。
PLoS One. 2012;7(7):e40484. doi: 10.1371/journal.pone.0040484. Epub 2012 Jul 6.
5
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.仅含LIM结构域蛋白2(LMO2)通过两条不同途径诱发T细胞白血病。
PLoS One. 2014 Jan 21;9(1):e85883. doi: 10.1371/journal.pone.0085883. eCollection 2014.
6
LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.LMO2癌蛋白在T细胞白血病中的稳定性需要直接与LDB1结合。
Mol Cell Biol. 2015 Nov 23;36(3):488-506. doi: 10.1128/MCB.00901-15. Print 2016 Feb 1.
7
Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.白血病癌基因 LMO2 的结构:对造血转录因子复合物组装的影响。
Blood. 2011 Feb 17;117(7):2146-56. doi: 10.1182/blood-2010-07-293357. Epub 2010 Nov 12.
8
LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.仅含LIM结构域的蛋白Lmo2与红系转录因子GATA-1形成蛋白复合物。
Leukemia. 1997 Apr;11 Suppl 3:307-12.
9
Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.致癌性DNA结合复合物LMO2-Ldb1-TAL1-E12的组装
Proteins. 2008 Mar;70(4):1461-74. doi: 10.1002/prot.21638.
10
LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.LMO2是TAL1 DNA结合活性以及成血管细胞阶段确定性造血起始所必需的。
Nucleic Acids Res. 2017 Sep 29;45(17):9874-9888. doi: 10.1093/nar/gkx573.

引用本文的文献

1
Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells.多模块结构的基因调控网络对鼠 T 细胞的鉴定和定型。
Front Immunol. 2023 Jan 31;14:1108368. doi: 10.3389/fimmu.2023.1108368. eCollection 2023.
2
Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition.具有高bHLH表达的实验性胶质瘤存在复制应激增加,并且对ATR抑制敏感。
Neurooncol Adv. 2020 Sep 10;2(1):vdaa115. doi: 10.1093/noajnl/vdaa115. eCollection 2020 Jan-Dec.
3
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?

本文引用的文献

1
LMO2 induces T-cell leukemia with epigenetic deregulation of CD4.LMO2 诱导 T 细胞白血病,导致 CD4 的表观遗传失调。
Exp Hematol. 2014 Jul;42(7):581-93.e5. doi: 10.1016/j.exphem.2014.04.010. Epub 2014 May 2.
2
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.仅含LIM结构域蛋白2(LMO2)通过两条不同途径诱发T细胞白血病。
PLoS One. 2014 Jan 21;9(1):e85883. doi: 10.1371/journal.pone.0085883. eCollection 2014.
3
Causal analysis approaches in Ingenuity Pathway Analysis.Ingenuity 通路分析中的因果分析方法。
白血病中的ZEB蛋白:朋友、敌人还是亦敌亦友?
Hemasphere. 2018 May 11;2(3):e43. doi: 10.1097/HS9.0000000000000043. eCollection 2018 Jun.
4
Genomic Profiling of T-Cell Neoplasms Reveals Frequent and Mutations With Clonal Evasion From Targeted Therapies.T细胞肿瘤的基因组分析揭示了频繁的突变以及对靶向治疗的克隆逃避。
JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00019. Epub 2018 Feb 13.
5
LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.LMO2癌蛋白在T细胞白血病中的稳定性需要直接与LDB1结合。
Mol Cell Biol. 2015 Nov 23;36(3):488-506. doi: 10.1128/MCB.00901-15. Print 2016 Feb 1.
6
Hhex is Required at Multiple Stages of Adult Hematopoietic Stem and Progenitor Cell Differentiation.在成体造血干细胞和祖细胞分化的多个阶段均需要Hhex。
Stem Cells. 2015 Aug;33(8):2628-41. doi: 10.1002/stem.2049. Epub 2015 May 27.
Bioinformatics. 2014 Feb 15;30(4):523-30. doi: 10.1093/bioinformatics/btt703. Epub 2013 Dec 13.
4
Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.E2A 核心抑制因子相互作用在不同白血病发病机制中的差异参与。
Nucleic Acids Res. 2014 Jan;42(1):137-52. doi: 10.1093/nar/gkt855. Epub 2013 Sep 24.
5
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.Lyl1 在 Lmo2 驱动的早期 T 细胞前体 ALL 模型中的需求。
Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.
6
Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.LMO2 驱动 SCL:E47bHLH 异二聚体募集到造血特异性转录靶标的结构基础。
Cell Rep. 2013 Jul 11;4(1):135-47. doi: 10.1016/j.celrep.2013.06.008. Epub 2013 Jul 3.
7
Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia.Lmo2 在白血病发生前诱导 T 细胞祖细胞中出现造血干细胞样特征。
Stem Cells. 2013 May;31(5):882-94. doi: 10.1002/stem.1345.
8
LIM-domain-only proteins in cancer.LIM 结构域蛋白与癌症。
Nat Rev Cancer. 2013 Feb;13(2):111-22. doi: 10.1038/nrc3418. Epub 2013 Jan 10.
9
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.人类 T 细胞急性淋巴细胞白血病中由 TAL1 复合物控制的核心转录调控回路。
Cancer Cell. 2012 Aug 14;22(2):209-21. doi: 10.1016/j.ccr.2012.06.007.
10
Targeting nonclassical oncogenes for therapy in T-ALL.针对 T-ALL 中的非典型癌基因进行治疗。
Cancer Cell. 2012 Apr 17;21(4):459-72. doi: 10.1016/j.ccr.2012.02.029.